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the severity of AR after TAVI as compared to c-MRI. Furthermore, there is a
poor correlation between c-MRI and TTE or angiography. Further studies are
mandatory to confirm our results in a larger population. 
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Background: Previous studies suggested that a low flow defined as an
indexed stroke volume (SVi) < 35 ml/m2 may be an important determinant of
outcome in patients with severe aortic stenosis (AS). However, its quantifica-
tion using echocardiography may be subject to error measurement. The aim of
this study is to determine the impact of low SVi determined during cardiac
catheterization on long-term survivalamong patients with severe aortic ste-
nosis and preserved LV ejection fraction.
Methods and Results: Between 2000 and 2010, 768 patients with pre-
served LVEF (>50%) and severe AS (valve area ≤1cm²) without other val-
vular heart disease underwent cardiac catheterization. SVi was derived from
catheterization data.
Mean age was 74±8 years, 42% were female, 46% had coronary artery dis-
ease and mean LVEF was 72±10%. Overall, low SVi was found in 27%
(n=...) of AS patients.
As compared to patients with normal SVi, those with decreased SVi were sig-
nificantly older (p<0.0001) and had more frequently atrial fibrillation (p<0.0001)
in addition, they had lower LVEF (p=0.04),; aortic valve area (p<0.0001), mean
pressure gradient (p= 0.001), systemic arterial compliance (p<0.0001) and higher-
systemic vascular and pulmonary resistances (p<0.0001). 
Ten-year survival was significantly reduced in patients with lower SVi
as compared to those with normal SVi (41±5% vs. 63±3%; p=0.0007,
Figure). After adjustment for all other risk factors, SVi was independently
associated with long-term survival (hazard ratio =0.97, 95%CI: 0.95-0.99;
p=0.01). 
Conclusion: Low SVi measured invasively is frequent in patients with
severe AS and preserved LVEF and is a powerful and independent predictor
of survival. SVi should be systematically measured and used as an additional
parameter for risk stratification of patients with severe AS. 
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Objectives: To evaluate feasibility, safety and advantage of underexpan-
sion of Edwards SAPIEN XT prosthesis during transcatheter aortic valve
implantation (TAVI).
Methods: We retrospectively analyzed 157 transfemoral TAVI proce-
dures performed between October 2012 and December 2013 in the Univer-
sity Hospital of Rouen. Thirty-six (22.9%) patients had intentional
underexpansion of the EDWARDS SAPIEN XT prosthesis since more than
20% area oversizing was anticipated with Computed tomography (CT)
assessment of aortic annulus. Underexpansion of Edwards SAPIEN XT
prosthesis was performed by reducing the volume of fluid within the valve
deployment balloon. The Primary endpoint was aortic regurgitation (AR)
at the end of the procedure. 
Results: Mean age was 83.4±5.8 years and the mean logistic EuroSCORE
of 15.4±9.6%. The initial fluid volume used for valve deployment was
90.1±3.1% of the theorical total volume (TTV) without significant difference
among the 3 sizes of prostheses (90.2±4.1%, 89.5±2.6%, and 84.8±3.2% for
23, 26, and 29-mm valves, respectively). AR immediately after the first infla-
tion was grade ≤I in 20 (55.6%) pts, grade II in 9 (25%) pts, and grade III in
7 (19.4%) pts. Stent diameter measured immediately after first inflation repre-
sented 94.2±4.1% of the prosthesis theorical diameter. Post-dilatation was
deemed necessary in 14 cases (39.4%). At the end of the procedure, AR was
< grade I in 34 (94.4%) patients and grade II in the 2 remaining patients. After
post-dilatation, one patient presenting with fatal aortic annulus rupture. Other
procedures were safe without stroke, myocardial infarction, or prosthesis
migration. 
Conclusion: Our study suggest that underexpansion of Edwards SAPIEN-
XT prosthesis is feasible during transfemoral TAVI procedures when more
than 20% area oversizing is anticipated by CT. However, post-dilatation is
mandatory in about 40% of cases to reduce significant residual aortic regurgi-
tation but can be complicated by aortic annulus rupture 
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Aim: Transcatheter aortic valve implantation (TAVI) is an alternative to
surgical aortic valve replacement for high-risk patients. The relative event
rates following TAVI have not yet been well described and seem to differ
between genders. We sought to determine gender imbalances in TAVI patients
with regard to baseline presentation, management, and prognosis.
Methods and results: A total of 3,972 patients underwent TAVI and were
prospectively included in the FRANCE 2 registry.
Women (n=1967) presented with older age and lower rates of coronary
artery disease, chronic obstructive pulmonary disease, renal failure, and
arrhythmia, though higher prevalence of hypertension and congestive heart
failure (43.7% vs. 39.7%; p=0.010). EuroSCORE was similar between gen-
ders. Women presented with smaller aortic annulus and were implanted with
smaller bioprostheses.
At 1 month, mortality rates were similar between genders. Multivariate
analysis revealed the following independent predictors for 1-month all-cause
mortality: female gender; New York Heart Association (NYHA) Class III or
IV; transapical approach; moderate to severe postprocedural aortic regurgita-
tion. We observed a specific interaction between gender and EuroSCORE,
confirming EuroSCORE as less capable to discriminate women in order to
establish 1-month mortality. Women presented with lower 1-year mortality
rates than men (19.3% vs. 23.7%; p=0.021). Female gender was an indepen-
dent predictor of 1-year survival (HR: 0.71, 95% CI: [0.57-0.88]).
Conclusion: Men and women exhibited several differing baseline charac-
teristics, as well as procedural and clinical outcomes. Notably, Euroscore
proved inconvenient for 1-month survival prediction in women. Women also
presented with an 18.5% decrease in 1-year all-cause mortality compared to
men. 
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